nafenopin has been researched along with Body Weight in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, K; Furuya, K; Numoto, S; Williams, GM | 1 |
| Garberg, P; Thullberg, M | 1 |
| Grasl-Kraupp, B; Gschwentner, C; Huber, WW; Lang, H; Schulte-Hermann, R; Stekel, H | 1 |
| Levine, WG; Ord, MG; Stocken, LA | 1 |
| Braunstein, HR; Levine, WG; Mejier, DK | 1 |
| Dirven, HA; Jongeneelen, FJ; Noordhoek, J; Peters, JG; van den Broek, PH | 1 |
| Bursch, W; Gerbracht, U; Kraus, P; Putz, B; Reinacher, M; Schulte-Hermann, R; Timmermann-Trosiener, I | 1 |
| Chelo, A; Columbano, A; Curto, M; Ennas, MG; Ledda-Columbano, GM; Pani, P | 1 |
| Gerbracht, U; Huber, W; Kraupp-Grasl, B; Putz, B; Schulte-Hermann, R | 1 |
| Furukawa, K; Furukawa, NT; Furuya, K; Numoto, S; Williams, GM | 1 |
| Giacobino, JP; Girardier, L; Seydoux, J | 1 |
| MacDonald, RS; Swan, PB | 1 |
| Furuya, K; Levine, WG; Mori, H; Numoto, S; Williams, GM | 1 |
13 other study(ies) available for nafenopin and Body Weight
| Article | Year |
|---|---|
Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Alkaline Phosphatase; Animals; Body Weight; Cell Division; Cell Membrane; Clofibrate; gamma-Glutamyltransferase; Histocytochemistry; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nafenopin; Organ Size; Propionates; Rats; Rats, Inbred F344 | 1984 |
Decreased glutathione peroxidase activity in mice in response to nafenopin is caused by changes in selenium metabolism.
Topics: Animals; Blotting, Northern; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Glutathione Peroxidase; Kidney; Liver; Male; Mice; Mice, Inbred Strains; Microbodies; Myelin P2 Protein; Nafenopin; Neoplasm Proteins; Nerve Tissue Proteins; Organ Size; Oxidation-Reduction; Proteins; RNA, Messenger; Selenium; Testis | 1996 |
Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil.
Topics: Animals; Body Weight; Carcinogens; Carnitine O-Acetyltransferase; Corn Oil; Drug Therapy, Combination; Eating; Lipid Peroxidation; Liver; Male; Microbodies; Nafenopin; Rats; Rats, Wistar; Triglycerides | 1997 |
Some biochemical changes associated with nafenopin-induced liver growth in the rat.
Topics: Aminoisobutyric Acids; Animals; Body Weight; DNA; Eating; Liver; Liver Regeneration; Male; Nafenopin; Organ Size; Ornithine Decarboxylase; Propionates; Rats; Stimulation, Chemical; Time Factors | 1977 |
Effect of nafenopin (SU-13,437) on liver function: mechanism of choleretic effect.
Topics: Animals; Bile; Bile Acids and Salts; Bile Ducts, Intrahepatic; Biliary Fistula; Body Water; Body Weight; Enterohepatic Circulation; Erythritol; Kinetics; Liver; Male; Nafenopin; Organ Size; Plasma Volume; Propionates; Rats; Sodium | 1975 |
Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
Topics: Adipates; Animals; Aroclors; Body Weight; Chlorodiphenyl (54% Chlorine); Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Enzyme Induction; Male; Methylcholanthrene; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Nafenopin; Organ Size; Oxidoreductases; Phenobarbital; Rats; Rats, Inbred Strains | 1992 |
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Topics: Animals; Body Weight; Carcinogens; Cell Survival; Clofibrate; Cyproterone; Cyproterone Acetate; Female; Glutathione Transferase; Hexachlorocyclohexane; Liver; Liver Neoplasms, Experimental; Nafenopin; Nitrosamines; Organ Size; Phenobarbital; Phenotype; Precancerous Conditions; Propionates; Rats; Rats, Inbred Strains | 1990 |
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci.
Topics: Adenosine Triphosphatases; Animals; Body Weight; Carbon Tetrachloride; Cell Division; Diethylnitrosamine; Ethylene Dibromide; gamma-Glutamyltransferase; Hyperplasia; Lead; Liver; Liver Neoplasms; Male; Nafenopin; Nitrates; Propionates; Rats; Rats, Inbred Strains | 1990 |
Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Topics: Aflatoxin B1; Aflatoxins; Animals; Body Weight; Carcinoma; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Nafenopin; Phenobarbital; Propionates; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Topics: Animals; Body Weight; Catalase; gamma-Glutamyltransferase; Glutathione Peroxidase; Glutathione Transferase; In Vitro Techniques; Kinetics; Liver; Liver Neoplasms; Male; Microbodies; Nafenopin; Organ Size; Phenobarbital; Propionates; Rats; Rats, Inbred F344 | 1985 |
Effect of nafenopin, a peroxisome proliferator, on energy metabolism in the rat as a function of acclimation temperature.
Topics: Acclimatization; Acyl Coenzyme A; Adipose Tissue, Brown; Animals; Body Temperature; Body Weight; Eating; Energy Metabolism; In Vitro Techniques; Male; Microbodies; Mitochondria; Nafenopin; Oxygen Consumption; Propionates; Proteins; Rats; Rats, Inbred Strains; Succinate Dehydrogenase | 1986 |
The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
Topics: Animals; Body Weight; Catalase; Clofibrate; Clofibric Acid; Fibric Acids; Hypolipidemic Agents; Male; Microbodies; Mitochondria, Heart; Mitochondria, Muscle; Muscles; Myocardium; Nafenopin; Oxidation-Reduction; Palmitates; Palmitic Acids; Rats; Rats, Inbred Strains | 1986 |
Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Administration, Oral; Animals; Body Weight; Carcinogens; Drug Synergism; Liver Neoplasms; Male; Nafenopin; Neoplasms, Experimental; Phenobarbital; Propionates; Rats; Rats, Inbred F344 | 1985 |